Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.

Authors

null

Nicolas Guibert

Inserm, Centre de Recherche en Cancérologie de Toulouse, CRCT UMR-1037, Toulouse, France

Nicolas Guibert, Greg Jones, John F. Beeler, Clive D. Morris, Vincent Plagnol, Jean Mourlanette, Myriam Delaunay, Isabelle Rouquette, Gilles Favre, Anne Pradines, Julien Mazieres

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Clinical Trial Registration Number

NCT02827344

Citation

J Clin Oncol 37, 2019 (suppl 8; abstr 103)

DOI

10.1200/JCO.2019.37.8_suppl.103

Abstract #

103

Poster Bd #

A5

Abstract Disclosures

Similar Posters

First Author: Jordan Kardos

First Author: Samuel Rosner

Poster

2021 ASCO Annual Meeting

Genomic landscape differences in patients with advanced non-small cell lung cancer by sex and age.

Genomic landscape differences in patients with advanced non-small cell lung cancer by sex and age.

First Author: ErinMarie Kimbrough